| Literature DB >> 32029688 |
Richard Y Ebright1, Sooncheol Lee1, Ben S Wittner1, Kira L Niederhoffer1, Benjamin T Nicholson1, Aditya Bardia1,2, Samuel Truesdell1, Devon F Wiley1, Benjamin Wesley1, Selena Li1, Andy Mai1, Nicola Aceto1, Nicole Vincent-Jordan1, Annamaria Szabolcs1, Brian Chirn1, Johannes Kreuzer1, Valentine Comaills1, Mark Kalinich1, Wilhelm Haas1,2, David T Ting1,2, Mehmet Toner3,4,5, Shobha Vasudevan1,2, Daniel A Haber6,2,7, Shyamala Maheswaran6,5, Douglas S Micalizzi1,2.
Abstract
Circulating tumor cells (CTCs) are shed into the bloodstream from primary tumors, but only a small subset of these cells generates metastases. We conducted an in vivo genome-wide CRISPR activation screen in CTCs from breast cancer patients to identify genes that promote distant metastasis in mice. Genes coding for ribosomal proteins and regulators of translation were enriched in this screen. Overexpression of RPL15, which encodes a component of the large ribosomal subunit, increased metastatic growth in multiple organs and selectively enhanced translation of other ribosomal proteins and cell cycle regulators. RNA sequencing of freshly isolated CTCs from breast cancer patients revealed a subset with strong ribosome and protein synthesis signatures; these CTCs expressed proliferation and epithelial markers and correlated with poor clinical outcome. Therapies targeting this aggressive subset of CTCs may merit exploration as potential suppressors of metastatic progression.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32029688 PMCID: PMC7307008 DOI: 10.1126/science.aay0939
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728